Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MA-NCD vs Megace in AIDS-related Wasting
NCT00637572Phase 2Completed
- Sponsor
- Endo International plc
- Start
- Dec 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial of megestrol in AIDS-related wasting syndrome (AWS) (2 arms), sponsored by Endo International plc. Primary endpoint: Change in Body Weight at 12 weeks. Started Dec 2004; status: completed.
02
Drugs
megestrol
03
Conditions
AIDS-related wasting syndrome (AWS)
Beyond the preview
Go deeper on NCT00637572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637572.